Harmony Biosciences Holdings, Inc.
HRMY
$28.46
$0.521.86%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 49.48M | 46.09M | 11.59M | 38.33M | 26.61M |
| Total Depreciation and Amortization | 5.97M | 5.97M | 6.05M | 6.12M | 6.13M |
| Total Amortization of Deferred Charges | 169.00K | 175.00K | 176.00K | 180.00K | 185.00K |
| Total Other Non-Cash Items | 4.13M | 6.56M | 39.31M | 6.83M | 12.10M |
| Change in Net Operating Assets | 15.82M | 11.70M | -14.51M | -20.33M | 31.64M |
| Cash from Operations | 75.56M | 70.50M | 42.62M | 31.14M | 76.67M |
| Capital Expenditure | -513.00K | -3.00K | -632.00K | -5.00K | -107.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 0.00 | 0.00 | -33.07M | -- | -36.97M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -6.67M | 748.00K | -21.16M | -6.18M | 1.01M |
| Cash from Investing | -7.19M | 745.00K | -54.86M | -6.19M | -36.07M |
| Total Debt Issued | -- | -- | -- | -- | 0.00 |
| Total Debt Repaid | -3.75M | -3.75M | -3.75M | -3.75M | -3.75M |
| Issuance of Common Stock | 3.24M | 2.58M | 573.00K | 116.00K | 227.00K |
| Repurchase of Common Stock | -2.23M | 0.00 | -269.00K | -- | -50.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Financing | -2.74M | -1.18M | -3.45M | -3.63M | -53.52M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 65.63M | 70.07M | -15.69M | 21.32M | -12.92M |